Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
110M
-
Shares change
-
-1.61M
-
Total reported value, excl. options
-
$939M
-
Value change
-
-$14.3M
-
Put/Call ratio
-
2.96
-
Number of buys
-
47
-
Number of sells
-
-46
-
Price
-
$8.57
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q1 2018
139 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2018.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110M shares
of 363M outstanding shares and own 30.2% of the company stock.
Largest 10 shareholders include Artal Group S.A. (58.3M shares), FMR LLC (15.8M shares), Ulys, L.L.C. (4.32M shares), BlackRock Inc. (4.23M shares), UBS ASSET MANAGEMENT AMERICAS INC (4.01M shares), VANGUARD GROUP INC (3.74M shares), USS Investment Management Ltd (2.74M shares), STATE STREET CORP (2.67M shares), NEA Management Company, LLC (2.38M shares), and CLEARBRIDGE, LLC (1.17M shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.